Industry News

NLS Diagnosis of Prostate Diseases by Metatron Hunter

More and more physicians have the opportunity to screen for NLS diagnosis of prostate and bladder. In the West, prostate cancer accounts for 20% of the total number of cancer diseases and is second only to lung cancer in causes of death.

According to some autopsy results of prostate histological investigations, 12-47% of men over 50 years old seem to have cancerous nephropathy. Clinically, cancer is diagnosed less often, because a large part of this number corresponds to less aggressive "secondary forms" of cancer, so patients with cancer die from another pathology.

To improve the quality of diagnosis of prostate diseases, it is important to know the details of the topography and regional anatomy of a specific organ.

The prostate is located in the small pelvis between the bladder and the anterior abdominal wall, the anterior rectal wall and the secondary urogenital diaphragm. The gland has a chestnut shape and tightly envelops the bladder cervix and the prostatic urethra. The base of the gland is gently connected to the bladder as a coherent mass. Its anterior surface points to the commissure, and the posterior surface to the ampulla of the rectum. The posterior surface of the gland has a distinct groove that allows the gland to be routinely subdivided into left and right lobes. In addition, there is a prominent middle conical lobe with the prostatic urethra in the front and the seminiferous ducts in the back.

According to the theory of zonular anatomy, 4 glandular zones are usually distinguished in the prostate. The correct interpretation of NLS data depends largely on the knowledge of their thematic pattern. 20% of the glandular tissue corresponds to the central zone (CZ). The peripheral zone (PZ) accounts for 75%. The intermediate (temporary) zone (TZ) accounts for 5% of the total glandular tissue.

If any pathological changes are detected in the NLS map, it is recommended to:
- specify their exact location;
- perform tissue imaging of the pathological area and the tissue area with normal architecture.

This will facilitate the follow-up of the case. In benign hyperplasia, NLS is able to detect the direction of the main sprouting. In the case of hypertrophic transition zones, the glands proliferate inwards. Despite the formation of dark lateral zones (4-5 points on the Flandler scale), the nodes can always be seen. Transrectal NLS provides the most detailed and realistic information.

As can be seen from NLS studies, chronic prostatitis does not give a common characteristic graph, but the morphological processes of different stages of the disease are reflected in the histogram. With long-lasting disease, the color density tends to rise due to the post-inflammatory replacement of glandular components and their histograms. In the "organ preparation" mode, the deconstruction of the fibrous components begins to dominate.

The analysis of the nidi histogram helps to distinguish neoplastic processes. The sensitivity of this method becomes higher with the use of the "elimination" and "NLS analysis" modes. In terms of cancer incidence, the peripheral zones are at the top. They account for 70-80% of the cases. The transition zone (TZ) is affected in 10-20% of cases, and the CZ in less than 5%. In the transition zone, neoplastic foci should be sought within 3-4 mm from the capsule. In case of tumor alertness, the symmetry of lobe influence is assessed according to the sagittal axis and the intensity of black plaques (4-5 points on the Flandler scale), in adjacent organs, especially the seminal vesicles and bladder, since in 25% of cases metastasis occurs through the glandular apex and spermatogenic tract.

Considering that cancer often develops with some diffuse changes occurring in the background, such as chronic prostatitis or adenomatosis, it is not always possible to see newly formed areas of cancer. In this case, the PSA level definition and the results of the digital rectal examination should be taken into account. The definition of the PSA level takes into account the patient's age and glandular volume.

The NLS method of Metatron Hunter can diagnose most prostate diseases and is a screening diagnostic method that should be supplemented with a biopsy if any pathological changes are detected.

The final diagnosis should be made only on the basis of clinical laboratory data and the results of the digital rectal examination in combination with a biopsy.